Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiang-Min Cheng

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Molecular Endocrinology (Baltimore, Md.)|June 27, 2012
COUP-TFII is a major regulator of cell cycle and Notch signaling pathwaysXinpu Chen, Jun Qin, Chiang-Min Cheng, et al.
Molecular and Cellular Biology|December 30, 2010
Compartmentalized Ras proteins transform NIH 3T3 cells with different efficienciesChiang-Min Cheng, Huiling Li, Stéphane Gasman, et al.
Developmental Cell|June 4, 2013
Atrial identity is determined by a COUP-TFII regulatory networkSan-pin Wu, Chiang-Min Cheng, Rainer B Lanz, et al.
Nature|December 4, 2012
COUP-TFII inhibits TGF-β-induced growth barrier to promote prostate tumorigenesisJun Qin, San-Pin Wu, Chad J Creighton, et al.
Science Advances|June 5, 2020
Small-molecule inhibitor targeting orphan nuclear receptor COUP-TFII for prostate cancer treatmentLeiming Wang, Chiang-Min Cheng, Jun Qin, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Molecular Endocrinology (Baltimore, Md.)|June 27, 2012
COUP-TFII is a major regulator of cell cycle and Notch signaling pathwaysXinpu Chen, Jun Qin, Chiang-Min Cheng, et al.
Molecular and Cellular Biology|December 30, 2010
Compartmentalized Ras proteins transform NIH 3T3 cells with different efficienciesChiang-Min Cheng, Huiling Li, Stéphane Gasman, et al.
Developmental Cell|June 4, 2013
Atrial identity is determined by a COUP-TFII regulatory networkSan-pin Wu, Chiang-Min Cheng, Rainer B Lanz, et al.
Nature|December 4, 2012
COUP-TFII inhibits TGF-β-induced growth barrier to promote prostate tumorigenesisJun Qin, San-Pin Wu, Chad J Creighton, et al.
Science Advances|June 5, 2020
Small-molecule inhibitor targeting orphan nuclear receptor COUP-TFII for prostate cancer treatmentLeiming Wang, Chiang-Min Cheng, Jun Qin, et al.
Pageof 1